Echo Health Ventures

Echo Health Ventures is a venture capital firm that focuses on investing in health care companies. From offices in Durham, Portland, and Seattle, Echo Health Ventures invests in health care companies. They work with portfolio companies to accelerate their innovations to scale nationally. As stage-agnostic investors, they are committed to a new approach to strategic investing – an approach that brings more than capital to the table, an approach focused on developing deep, high-value relationships with their portfolio companies.

Karim Botros

Managing Partner

Lindsey Brown

Senior Associate, Strategic Investment

Robert Dolan

Managing Principal, Echo Health Advisors

Jon Eide

Managing Partner and COO

David Goad

Senior Associate, Strategic Investment

Jose Guerola

Principal, Strategic Investment

Dusty Lieb

Partner

Maura Little

Managing Principal, Echo Health Advisors

Suzanne McLemore

Managing Partner and Head of Echo Health Advisors

Kurt Sheline

Partner

Annie Weissbach

Senior Associate, Strategic Investment

Pia Shivdasani Ph.D

Associate Principal, Echo Health Advisors

41 past transactions

Abacus Insights

Series C in 2022
Abacus Insights offers a data management solution that standardizes data across the healthcare ecosystem by providing a highly secure unified data infrastructure that minimizes change management and maximizes analytics enablement to help healthcare providers improve costs and member outcomes for customers. Abacus Insights delivers intelligent data management capabilities for actionable insights. It was founded in 2017 and headquartered in New York City.

Waltz Health

Series A in 2022
Waltz will work with every partner in the pharmaceutical supply chain, including consumers, payers and pharmacies to create smarter, technology-enabled ways to price, distribute and prescribe medications.

Embold Health

Series B in 2022
Embold Health their online search platform, for both mobile and desktop where people can identify provider in medical research and clinical guidelines.

Wildflower Health

Venture Round in 2022
Wildflower Health focuses on its client's needs and integrates services into existing sustainability programs. Its team is passionate about harnessing user-centered design and technology to deliver products that drive smarter healthcare decisions. It was founded in 2012 and headquartered in San Francisco, California.

Scipher Medicine

Series D in 2022
Scipher Medicine develops a healthcare platform designed to determine which drug will work best for each patient. The company is committed to transforming the way providers prescribe drugs, as well as the way manufacturers, develop new drugs. They are building a molecular map of all protein interactions that identifies genomic signatures and links those to disease and predictive treatment outcomes. Using a simple blood sample to analyze RNA, Scipher Medicine can predict if a patient is likely to respond to a targeted therapy before therapy is prescribed. This insight allows patients to start the most effective therapy from day one. For its first commercial product, they have developed PrismRA®, a first-of-its-kind blood test that can predict which patients with rheumatoid arthritis are less likely to respond to TNFi therapies such as Humira® and Enbrel® so that such patients can go on alternative approved drugs. Scipher Medicine is building the future of patient treatment. Most patients who are prescribed blockbuster therapies today don't respond to treatment, costing the healthcare industry billions in wasted drugs while patients continue to suffer. Scipher's platform identifies which drug will work based on the patient's fundamental disease biology, and not based on symptoms, disease classification, or medical bias. A routine blood test predicts which drug he/she will respond to, with our first product focusing on rheumatoid arthritis, ensuring that the most optimal treatment is prescribed from day one. The molecular data generated by our tests are then used to fuel novel target discovery to address a clear unmet medical need in patients who do not respond to any existing therapy.

mPulse Mobile

Venture Round in 2022
MPulse Mobile specializes in conversational AI and digital engagement solutions for the healthcare industry. The company combines technology, analytics, and industry expertise that helps healthcare organizations activate their customers to adopt healthy behaviors.

Genome Medical

Series C in 2021
Genome Medical is a national telegenomics technology, services, and strategy company bringing genomic medicine to everyday care. Through its nationwide network of genetic specialists and an efficient Genome Care DeliveryTM technology platform, we provide expert virtual genetic care for individuals and their families to improve health and well-being. They also help health care providers and their patients navigate the rapidly expanding field of genetics and utilize test results to understand the risk for disease, accelerate disease diagnosis, make informed treatment decisions and lower the cost of care.

Vori Health

Series A in 2021
Vori Health offers a new care delivery model for treating musculoskeletal conditions. Its nationwide, all-inclusive medical practice is evidence-based and uniquely positioned to address a multitude of back, neck, and other joint issues. The organization offers integrated medical and rehabilitation care, physical therapy, prescriptions, imaging and lab ordering, health coaching, nutritional guidance, community support and premium instructional content. Using a unique, virtual-first care model to help patients find the best path forward, Vori Health connects patients to a trained care team that includes a board-certified, non-operative physical medicine physician, a health coach navigator, and a physical therapist who collaboratively manage the initial patient assessment and coordinate all aspects of care. Learn more at www.vorihealth.com. The company was founded in 2020 and is headquartered in New York, NY.

Main Street Health

Funding Round in 2021
Main Street Health is a provider of value-based, care-focused healthcare services aimed at addressing rural wellness concerns. The company's healthcare services are data-driven, and it provides partner clinics with employees, technology, critical access hospitals, community health centers, and possibilities to flourish in the care delivery model, allowing rural residents to receive the high-quality treatment they need.

Eleanor Health

Series B in 2021
Eleanor Health is the first addiction and mental health services provider designed to deliver long-term patient recovery outcomes and modeled on value-based care delivery and payments. Eleanor provides whole-person, comprehensive care for mental health and substance misuse through a network of outpatient clinics, virtually, and in the community and patient’s homes. Eleanor Health was founded in 2019 and headquartered in Waltham, Massachusetts.

Heartbeat Health

Series B in 2021
Heartbeat Health is a healthcare technology company that delivers virtual-first cardiovascular disease prevention and management. Through its data-powered platform and clinical services, the company helps patients and at-risk organizations benefit from higher-value care by reducing cardiovascular risk and the likelihood of future adverse events. It offers tools and resources critical to supporting digital care by virtually connect patients with doctors securely and helps in sharing information in real-time, and collaborate on treatment and diet consultation, and helps patients to keep track of their heart health and be in touch with a cardiologist.

Ideon

Series B in 2021
Ideon develops a healthcare data platform for the employee benefits sector. Its suite of application programming interfaces provides the infrastructure, or middleware, to help insurance and digital health companies access flows of data, creating modern digital experiences throughout the employee benefits ecosystem.

Cityblock Health

Series C in 2021
Cityblock Health is a tech-driven provider for communities with complex needs it focuses on investing upstream in highly personalized, prevention-oriented health and social care to ultimately drive down costs and improve outcomes. Its technology enables scale by bringing together practical information, coordination, and communication for its members and care teams. During COVID-19, Cityblock created a model to help organizations determine which of their members are at high risk of COVID-19.

Scipher Medicine

Series C in 2021
Scipher Medicine develops a healthcare platform designed to determine which drug will work best for each patient. The company is committed to transforming the way providers prescribe drugs, as well as the way manufacturers, develop new drugs. They are building a molecular map of all protein interactions that identifies genomic signatures and links those to disease and predictive treatment outcomes. Using a simple blood sample to analyze RNA, Scipher Medicine can predict if a patient is likely to respond to a targeted therapy before therapy is prescribed. This insight allows patients to start the most effective therapy from day one. For its first commercial product, they have developed PrismRA®, a first-of-its-kind blood test that can predict which patients with rheumatoid arthritis are less likely to respond to TNFi therapies such as Humira® and Enbrel® so that such patients can go on alternative approved drugs. Scipher Medicine is building the future of patient treatment. Most patients who are prescribed blockbuster therapies today don't respond to treatment, costing the healthcare industry billions in wasted drugs while patients continue to suffer. Scipher's platform identifies which drug will work based on the patient's fundamental disease biology, and not based on symptoms, disease classification, or medical bias. A routine blood test predicts which drug he/she will respond to, with our first product focusing on rheumatoid arthritis, ensuring that the most optimal treatment is prescribed from day one. The molecular data generated by our tests are then used to fuel novel target discovery to address a clear unmet medical need in patients who do not respond to any existing therapy.

Strive Health

Series B in 2021
Strive Health is a built-for-purpose company working with innovative payers and providers to transform kidney care. Strive Health significantly improves patient outcomes and experience with a high-touch, technology-enabled clinical model that cares for chronic kidney disease patients across their entire healthcare journey, from primary care-level engagement through dialysis. Strive was launched out of Oxeon’s Venture Studio and is backed by New Enterprise Associates, Town Hall Ventures, Echo Health Ventures, and Ascension Ventures.

DispatchHealth

Series D in 2021
DispatchHealth is a provider of mobile and virtual healthcare for people of all ages in the comfort of their own homes. DispatchHealt was founded in 2013 and was formerly known as True North Health Navigation. It aims to create an integrated, convenient, triage, and care delivery solution that extends the capabilities of the patient's care team and provides quality care in the home while decreasing costs. It was founded in 2013 and headquartered in Denver, Colorado.

Octave

Series B in 2020
Octave is a clinical platform developer who is working to create a new paradigm of multiple sclerosis care by generating, analyzing, and combining data. The platform of the company provides an integrated and multi-dimensional approach to lowering total cost of care by optimizing healthcare medications and utilization, allowing pharma to optimize the entire lifecycle of drug discovery and development, clinical trials, and post-marketing with real-world evidence.
Upfront Healthcare creates a better ambulatory experience for all. With so much focus on increasing ambulatory volume without inserting efficient ways to qualify and prepare for the visit, many appointments result in wasted effort, disappointing all parties involved. The company's Care Traffic Control platform proactively reassures and directs patients to the safest and most relevant care options within the health system. Using advanced analytics, personalized content, and strategic calls-to-action, Upfront aligns patient care needs with health system resources through a 1:1 digital experience based on deep healthcare operations and patient engagement experience. Upfront Healthcare Services was established in 2015 and is based in Chicago, Illinois, USA.

mPulse Mobile

Series C in 2020
MPulse Mobile specializes in conversational AI and digital engagement solutions for the healthcare industry. The company combines technology, analytics, and industry expertise that helps healthcare organizations activate their customers to adopt healthy behaviors.

Cityblock Health

Series B in 2020
Cityblock Health is a tech-driven provider for communities with complex needs it focuses on investing upstream in highly personalized, prevention-oriented health and social care to ultimately drive down costs and improve outcomes. Its technology enables scale by bringing together practical information, coordination, and communication for its members and care teams. During COVID-19, Cityblock created a model to help organizations determine which of their members are at high risk of COVID-19.

DispatchHealth

Series C in 2020
DispatchHealth is a provider of mobile and virtual healthcare for people of all ages in the comfort of their own homes. DispatchHealt was founded in 2013 and was formerly known as True North Health Navigation. It aims to create an integrated, convenient, triage, and care delivery solution that extends the capabilities of the patient's care team and provides quality care in the home while decreasing costs. It was founded in 2013 and headquartered in Denver, Colorado.

Abacus Insights

Series B in 2020
Abacus Insights offers a data management solution that standardizes data across the healthcare ecosystem by providing a highly secure unified data infrastructure that minimizes change management and maximizes analytics enablement to help healthcare providers improve costs and member outcomes for customers. Abacus Insights delivers intelligent data management capabilities for actionable insights. It was founded in 2017 and headquartered in New York City.

Amwell

Series C in 2020
Amwell is a telehealth platform in the United States and globally, connecting and enabling providers, insurers, patients, and innovators to deliver greater access to more affordable, higher quality care. Amwell believes that digital care delivery will transform healthcare. The company offers a single, comprehensive platform to support all telehealth needs from urgent to acute and post-acute care, as well as chronic care management and healthy living. With over a decade of experience, Amwell powers telehealth solutions for over 240 health systems comprised of 2,000 hospitals and 55 health plan partners with over 36,000 employers, reaching over 150 million lives. Amwell was founded in 2006 and is headquartered in Boston, Massachusetts.

Aledade

Series C in 2020
Aledade is a primary care physician platform to provide everything the doctors to create and run an Accountable Care Organization. Aledade partners with independent, primary care physicians to provide everything the doctors need to create and run an Accountable Care Organization (ACO) from business and practice transformation services to upfront capital and a cutting-edge technology platform. The company's customized solutions and continuous on-the-ground support of our physician partners will help doctors in all types of communities across America preserve their autonomy, deliver better care to their patients, reduce overall costs, and keep independent physician practices flourishing. Adelade was founded in 2014 and is headquartered in Bethesda, Maryland, United States.

TytoCare

Venture Round in 2020
TytoCare is a mobile-health platform and device, that allows anyone to perform self-physical examination and remote diagnosis. Tyto Care has three telehealth products: the TytoHome for consumers, TytoPro for professionals, and TytoClinic for remote point-of-care locations. All solutions are designed to replicate a facetious clinician visit and include a modular examination tool for examining the heart, lungs, skin, throat, ears, and body temperature; a complete telehealth platform for sharing exam data, conducting live video exams, and scheduling visits; a cloud-based data repository with analytics; and built-in guidance technology and machine learning algorithms to ensure accuracy and ease of use.

Aitia

Series D in 2019
Aitia is the leader in the application of Causal AI and Digital Twins to discover the next generation of breakthrough drugs. By leveraging the convergence of multi-omic patient data, high-performance computing, and causal learning and AI, Aitia is revealing the hidden biological mechanisms of disease to create Digital Twins of disease in oncology, neurodegenerative disorders, and immunology. Gemini Digital Twins are being used today to discover novel therapies and accelerate R&D in multiple myeloma, prostate cancer, Alzheimer’s Disease, Parkinson’s Disease, and Huntington’s Disease, with several more in development. Aitia’s partners include seven of the top ten pharmaceutical companies, leading academic research and medical centers, medical societies, leading multi-omic data companies, and patient advocacy groups globally.

Genome Medical

Series B in 2019
Genome Medical is a national telegenomics technology, services, and strategy company bringing genomic medicine to everyday care. Through its nationwide network of genetic specialists and an efficient Genome Care DeliveryTM technology platform, we provide expert virtual genetic care for individuals and their families to improve health and well-being. They also help health care providers and their patients navigate the rapidly expanding field of genetics and utilize test results to understand the risk for disease, accelerate disease diagnosis, make informed treatment decisions and lower the cost of care.

Abacus Insights

Series A in 2019
Abacus Insights offers a data management solution that standardizes data across the healthcare ecosystem by providing a highly secure unified data infrastructure that minimizes change management and maximizes analytics enablement to help healthcare providers improve costs and member outcomes for customers. Abacus Insights delivers intelligent data management capabilities for actionable insights. It was founded in 2017 and headquartered in New York City.

DispatchHealth

Series B in 2019
DispatchHealth is a provider of mobile and virtual healthcare for people of all ages in the comfort of their own homes. DispatchHealt was founded in 2013 and was formerly known as True North Health Navigation. It aims to create an integrated, convenient, triage, and care delivery solution that extends the capabilities of the patient's care team and provides quality care in the home while decreasing costs. It was founded in 2013 and headquartered in Denver, Colorado.

Cityblock Health

Series B in 2019
Cityblock Health is a tech-driven provider for communities with complex needs it focuses on investing upstream in highly personalized, prevention-oriented health and social care to ultimately drive down costs and improve outcomes. Its technology enables scale by bringing together practical information, coordination, and communication for its members and care teams. During COVID-19, Cityblock created a model to help organizations determine which of their members are at high risk of COVID-19.

Strive Health

Seed Round in 2019
Strive Health is a built-for-purpose company working with innovative payers and providers to transform kidney care. Strive Health significantly improves patient outcomes and experience with a high-touch, technology-enabled clinical model that cares for chronic kidney disease patients across their entire healthcare journey, from primary care-level engagement through dialysis. Strive was launched out of Oxeon’s Venture Studio and is backed by New Enterprise Associates, Town Hall Ventures, Echo Health Ventures, and Ascension Ventures.

Aledade

Corporate Round in 2019
Aledade is a primary care physician platform to provide everything the doctors to create and run an Accountable Care Organization. Aledade partners with independent, primary care physicians to provide everything the doctors need to create and run an Accountable Care Organization (ACO) from business and practice transformation services to upfront capital and a cutting-edge technology platform. The company's customized solutions and continuous on-the-ground support of our physician partners will help doctors in all types of communities across America preserve their autonomy, deliver better care to their patients, reduce overall costs, and keep independent physician practices flourishing. Adelade was founded in 2014 and is headquartered in Bethesda, Maryland, United States.

Octave

Series A in 2018
Octave is a clinical platform developer who is working to create a new paradigm of multiple sclerosis care by generating, analyzing, and combining data. The platform of the company provides an integrated and multi-dimensional approach to lowering total cost of care by optimizing healthcare medications and utilization, allowing pharma to optimize the entire lifecycle of drug discovery and development, clinical trials, and post-marketing with real-world evidence.

AccessOne

Venture Round in 2018
AccessOne, founded in 2002 and headquartered in Fort Mill, South Carolina, is a prominent provider of patient payment solutions aimed at helping individuals manage their healthcare expenses while enhancing hospital revenue collection. The company specializes in offering a range of low and no-interest payment options for various patient balance types, including high-deductible and catastrophic plans, as well as financial assistance. AccessOne ensures that no patient is denied credit or has their credit reported, which supports a more inclusive approach to healthcare financing. Its financial engagement platform is designed for hospitals and health systems, focusing on automation and digitization to streamline patient communication and integration with major health information systems. This approach not only improves operational efficiency but also provides real-time functionality and performance metrics, ultimately aiding healthcare providers in capturing more revenue and improving financial outcomes.

mPulse Mobile

Series B in 2018
MPulse Mobile specializes in conversational AI and digital engagement solutions for the healthcare industry. The company combines technology, analytics, and industry expertise that helps healthcare organizations activate their customers to adopt healthy behaviors.

Livongo

Series E in 2018
Livongo is a consumer digital health company that empowers people with chronic conditions to live a better life. It has developed a completely new approach to diabetes management that combines the latest technology with coaching. By offering the right information, tools, and support, at the right time, we provide our members with real-time, personalized insights, and support to make diabetes management easier. Its approach is leading to better financial and clinical outcomes while also creating a better experience for people with diabetes and their care team of family, friends, and medical professionals. It was founded in 2008 and is headquartered in Mountain View, California.

Wildflower Health

Series C in 2018
Wildflower Health focuses on its client's needs and integrates services into existing sustainability programs. Its team is passionate about harnessing user-centered design and technology to deliver products that drive smarter healthcare decisions. It was founded in 2012 and headquartered in San Francisco, California.

Springbuk

Series B in 2018
Springbuk provides a health analytics software solution to prevent disease with data. Its health intelligence platform unifies medical claims, pharmacy, biometric, and activity data. The predictive modeling engine helps employers target their engagement with pinpoint accuracy, forecast overall healthcare spending, identify at-risk employees, and measure their wellness programs. The company was founded in 2015 and is headquartered in Indianapolis, Indiana.

Circulation

Series A in 2017
Circulation uses cutting-edge technology to manage the logistics and transportation throughout healthcare. It drives efficiency and better outcomes of populations throughout the U.S. As Uber’s Preferred Healthcare Partner, Circulation provides the first customizable, digital platform to coordinate convenient non-emergency transportation for all areas of healthcare. Circulation is utilized by patients, caregivers, providers, staff, and volunteers. The Circulation platform is compliant with the Health Insurance Portability and Accountability Act (HIPAA) to protect the privacy and security of its patients and clients. This platform seamlessly integrates with Uber’s API as well as other ride providers.
Upfront Healthcare creates a better ambulatory experience for all. With so much focus on increasing ambulatory volume without inserting efficient ways to qualify and prepare for the visit, many appointments result in wasted effort, disappointing all parties involved. The company's Care Traffic Control platform proactively reassures and directs patients to the safest and most relevant care options within the health system. Using advanced analytics, personalized content, and strategic calls-to-action, Upfront aligns patient care needs with health system resources through a 1:1 digital experience based on deep healthcare operations and patient engagement experience. Upfront Healthcare Services was established in 2015 and is based in Chicago, Illinois, USA.

Phreesia

Series B in 2007
Phreesia is a privately held company focused on patient check-in. The company replaces the outdated patient clipboard in physician offices with a free wireless touch screen and swipe card enabled PhreesiaPad. Phreesia automates the patient check-in process by collecting personal health information on the PhreesiaPad from the patient in a secure and HIPAA-compliant fashion. The product is designed to interface with physicians' existing and future technology and is compatible with electronic medical records (EMRs) Phreesia does not require any changes to the physician workflow and captures comprehensive patient information that can automatically be printed to reports for administrative and clinical staff. The company also improves the patient experience by better preparing them for their appointments, offering up-to-date health education relevant to their medical concerns, and enabling them to verify, rather than re-enter, information recorded at previous visits to the medical practice. The company draws on the expertise of a leading Medical Advisory Board and has initiated a series of patient care initiatives that concentrate on both wellness and disease prevention. The company is backed by premier venture capital firms and has received $13.25 million in financing to date.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.